-
Usage
India
-
Type
Antineoplastic Agent
-
Appearance
i
Imatinib mesylate is a targeted therapy. Imatinib mesylate is classified as a signal transduction inhibitor - protein-tyrosine kinase inhibitor.Used for treatment of newly diagnosed adult and pediatric patients with philadelphia chromosome positive chronic myeloid leukemia (ph+ cml) in chronic phase.Ph+ cml in blast crisis, accelerated phase, or chronic phase after failure of interferon-alpha therapy.Adult patients with relapsed or refractory philadelphia chromosome + acute lymphoblastic leukemia (ph+ all).Adult patients with myelodysplasticmyeloproliferative diseases (mdsmpd) associated with pdgfr gene rearrangements.Gastrointestinal stromal tumors that are c-kit positive.Imatinib mesylate is a pill, taken by mouth, once or twice daily.Imatinib mesylate should be taken with a large glass of water, after a meal.
Write a Review
Paramjeet Kaur (Admac Lifesciences)
Corporate OfficernSCO 84, Sector 5,rnPanchkula - 134112rnHaryana - India
Share us via
